Max Drawdown (5Y) Chart

Historical Max Drawdown (5Y) Data

View and export this data back to 2015. Start Trial.
Date Value
September 30, 2026 32.48%
August 31, 2026 32.48%
July 31, 2026 32.48%
June 30, 2026 32.48%
May 31, 2026 32.48%
April 30, 2026 32.48%
March 31, 2026 32.48%
February 28, 2026 32.48%
January 31, 2026 32.48%
December 31, 2025 32.48%
November 30, 2025 32.48%
October 31, 2025 32.48%
September 30, 2025 32.48%
August 31, 2025 32.48%
July 31, 2025 32.48%
June 30, 2025 32.48%
May 31, 2025 32.48%
April 30, 2025 32.48%
March 31, 2025 32.48%
February 28, 2025 32.48%
January 31, 2025 32.48%
December 31, 2024 32.48%
November 30, 2024 32.48%
October 31, 2024 32.48%
September 30, 2024 32.48%
Date Value
August 31, 2024 32.48%
July 31, 2024 32.48%
June 30, 2024 32.48%
May 31, 2024 32.48%
April 30, 2024 32.48%
March 31, 2024 32.48%
February 29, 2024 32.48%
January 31, 2024 32.48%
December 31, 2023 32.48%
November 30, 2023 23.47%
October 31, 2023 23.47%
September 30, 2023 23.47%
August 31, 2023 23.47%
July 31, 2023 23.47%
June 30, 2023 23.47%
May 31, 2023 23.47%
April 30, 2023 23.47%
March 31, 2023 23.47%
February 28, 2023 23.47%
January 31, 2023 23.47%
December 31, 2022 23.47%
November 30, 2022 23.47%
October 31, 2022 23.47%
September 30, 2022 23.47%
August 31, 2022 23.47%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
ProQR Therapeutics NV 97.50%
Pharming Group NV 60.45%
NewAmsterdam Pharma Co. NV 66.23%
Agenus, Inc. 98.84%
Amgen, Inc. 24.86%